Angelique Henley-Gagne

St Jérôme
Gagne, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Disease Burden in a Cohort of Canadian Adults With Moderate-to-Severe Atopic Dermatitis by Systemic Therapy Use.

Disease Burden in a Cohort of Canadian Adults With Moderate-to-Severe Atopic Dermatitis by Systemic Therapy Use.

Journal: Journal of cutaneous medicine and surgery

Published: March 26, 2026

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

Journal: Dermatology and therapy

Published: January 12, 2024

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.

Journal: Dermatology and therapy

Published: August 09, 2023

Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS).

Enhanced Effectiveness of Adalimumab Compared to Topical/Traditional Systemic Agents in the Treatment of Moderate to Severe Plaque Psoriasis: Results from a Canadian Observational Epidemiologic Study (COMPLETE-PS).

Journal: Dermatology and therapy

Published: December 21, 2021

Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.

Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.

Journal: American journal of clinical dermatology

Published: June 19, 2019

Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.

Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.

Journal: American journal of clinical dermatology

Published: March 18, 2018

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 25, 2017

C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells.

C-C chemokine receptor-7 mediated endocytosis of antibody cargoes into intact cells.

Journal: Frontiers in pharmacology

Published: July 22, 2013

Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs.

Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs.

Journal: Toxicology and applied pharmacology

Published: October 14, 2011

Unusual case of proximal calciphylaxis without renal failure.

Unusual case of proximal calciphylaxis without renal failure.

Journal: Journal of cutaneous medicine and surgery

Published: October 04, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026